Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul 12;29(31):5015-21.
doi: 10.1016/j.vaccine.2011.04.077. Epub 2011 May 10.

Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults

Affiliations

Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults

Xu Yao et al. Vaccine. .

Abstract

Annual immunization with a trivalent inactivated vaccine (TIV) is considered efficacious for prevention of seasonal influenza in older adults. However, significant controversy exists in the current literature regarding the clinical effectiveness of TIV immunization in this highly heterogeneous population. Frailty is an important geriatric syndrome characterized by decreased physiologic reserve and increased vulnerability to stressors. Using a validated set of frailty criteria, we conducted a prospective observational study to evaluate TIV-induced strain-specific hemagglutination inhibition (HI) antibody titers and post-vaccination rates of influenza-like illness (ILI) and infection in frail and nonfrail older adults. The results indicate that frailty was associated with significant impairment in TIV-induced strain-specific HI titers and increased rates of ILI and laboratory-confirmed influenza infection. These findings suggest that assessing frailty status in the elderly may identify those who are less likely to respond to TIV immunization and be at higher risk for seasonal influenza and its complications.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Pre-vaccination screening and blood draw, TIV immunization, as well as post-vaccination blood draw and influenza surveillance.
Fig. 2
Fig. 2
GMT ratios to H1N1, H3N2, and B strains in all study participants “All (n = 71)”, nonfrail (n = 22), prefrail (n = 32), and frail (n = 17) groups. p Values were derived from linear regression analysis for stepwise trend of decrease in nonfrail, prefrail, to frail study groups, adjusted for age.
Fig. 3
Fig. 3
Rates of influenza-like illness (ILI) (A) and laboratory confirmed influenza infection (B) during post-vaccination season. p Values were obtained from logistic regression analysis for stepwise trend of increase in nonfrail, prefrail, to frail study groups, adjusted for age.

References

    1. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004 September;292(11):1333–1340. - PubMed
    1. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007 June;25(227):5086–5096. - PubMed
    1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003 January;289(2):179–186. - PubMed
    1. Rivetti D, Jefferson T, Thomas R, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2006;3 CD004876. - PubMed
    1. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994 December;272(21):1661–1665. - PubMed

Publication types